GRAFT REJECTION
Clinical trials for GRAFT REJECTION explained in plain language.
Never miss a new study
Get alerted when new GRAFT REJECTION trials appear
Sign up with your email to follow new studies for GRAFT REJECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Breakthrough trial aims to free kidney patients from lifelong drugs
Disease control CompletedThis study tested whether kidney transplant patients could safely stop taking lifelong anti-rejection medications. Researchers gave patients stem cells from their donor sibling along with a special antibody treatment, then tried to gradually withdraw their immunosuppressive drugs…
Matched conditions: GRAFT REJECTION
Phase: NA • Sponsor: Northwestern University • Aim: Disease control
Last updated Apr 04, 2026 03:06 UTC
-
New test aims to spot kidney transplant problems earlier
Diagnosis CompletedThis study tested a new molecular analysis tool called HistoMx on kidney transplant biopsies to see if it helps doctors better diagnose rejection in real-world clinical practice. It involved 400 adult kidney transplant recipients and followed their outcomes for 12 months. The goa…
Matched conditions: GRAFT REJECTION
Sponsor: Paris Translational Research Center for Organ Transplantation • Aim: Diagnosis
Last updated Apr 04, 2026 03:05 UTC
-
Could pregnancy trigger rejection in transplant patients?
Knowledge-focused CompletedThis study looked at whether pregnancy increases the risk of organ rejection in women who have received lung transplants. Researchers examined 11 cases where women with lung transplants had pregnancies between 2012-2021. They compared genetic markers from the children, mothers, a…
Matched conditions: GRAFT REJECTION
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:57 UTC